Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Experimental HIV drug seems effective at a twice-a-year dose, study finds
Stat
Wed, 07/1/20 - 11:25 am
HIV
Gilead Sciences
lenacapavir
clinical trials
Go or no go? Pandemic looms over FDA timelines
EP Vantage
Wed, 07/1/20 - 10:54 am
Jazz Pharma
Gilead Sciences
Galapagos
GSK
FDA
pandemic
COVID-19
After its $2B Gilead pact, Goldfinch Bio nabs a cool $100M series B
Fierce Biotech
Tue, 06/30/20 - 10:38 am
Goldfinch Bio
Gilead Sciences
Kidney Genome Atlas
funding
Gilead's long-awaited remdesivir price is $3,120, in line with watchdog estimates
Fierce Pharma
Mon, 06/29/20 - 10:46 am
drug pricing
Gilead Sciences
COVID-19
remdesivir
Price for Gilead's COVID-19 drug should shrink if cheap steroid widely used, ICER says
BioPharma Dive
Thu, 06/25/20 - 07:25 pm
Gilead Sciences
remdesivir
ICER
drug pricing
steriod
Gilead pens $1.5B buyout option deal for Pionyr
Fierce Biotech
Tue, 06/23/20 - 10:50 am
Gilead Sciences
Pionyr
M&A
immuno-oncology
Gilead to Test Inhaled Form of Remdesivir in COVID-19 Starting in August
BioSpace
Mon, 06/22/20 - 08:43 pm
Gilead Sciences
remdesivir
inhaled drugs
COVID-19
pandemic
clinical trials
Does Gilead Have a Cure for the Coronavirus?
Motley Fool
Sun, 06/21/20 - 11:02 pm
Gilead Sciences
remdesivir
COVID-19
Gilead will test remdesivir in children with COVID-19
Pharmaforum
Thu, 06/18/20 - 10:34 am
Gilead Sciences
remdesivir
pediatric
clinical trials
COVID-19
Gilead sees better days ahead for CAR-T therapy Yescarta with Amsterdam manufacturing hub online
Fierce Pharma
Mon, 06/15/20 - 11:08 pm
Gilead Sciences
CAR-T
Yescarta
Amsterdam
drug manufacturing
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
Motley Fool
Sun, 06/14/20 - 10:49 pm
Gilead Sciences
HIV
bNab
AstraZeneca's Acquisition of Gilead Would Create a COVID-19 Colossus -- but Don't Bet on Seeing It Happen
Motley Fool
Tue, 06/9/20 - 12:19 pm
AstraZeneca
Gilead Sciences
M&A
COVID-19
Gilead files remdesivir for EU approval, with a verdict possible “in weeks”
Pharmaforum
Tue, 06/9/20 - 10:36 am
EMA
Europe
Gilead Sciences
remdesivir
COVID-19
Gilead builds case for filgotinib in active psoriatic arthritis
Fierce Biotech
Mon, 06/8/20 - 10:38 am
Gilead Sciences
Galapagos
filgotinib
clinical trials
psoriatic arthritis
AstraZeneca reportedly eyed a merger with Gilead. But does 'Gileaz' make sense?
Fierce Pharma
Mon, 06/8/20 - 10:33 am
M&A
Gilead Sciences
AstraZeneca
AstraZeneca Approaches Gilead About Potential Merger
Bloomberg
Sun, 06/7/20 - 10:53 pm
AstraZeneca
Gilead Sciences
M&A
Could Gilead's COVID-19 Drug Make $7 Billion Per Year?
Motley Fool
Sun, 06/7/20 - 10:25 pm
Gilead Sciences
COVID-19
remdesivir
Gilead shows durability of filgotinib ahead of face-off with AbbVie
Fierce Biotech
Thu, 06/4/20 - 11:00 am
Gilead Sciences
Galapagos
clinical trials
filgotinib
rheumatoid arthritis
Gilead's next step on coronavirus: inhaled remdesivir, other easier-to-use versions
Reuters
Tue, 06/2/20 - 11:19 pm
Gilead Sciences
drug development
remdesivir
COVID-19
Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs
Fierce Biotech
Tue, 06/2/20 - 10:46 am
Gilead Sciences
Mark Genovese
NASH
arthritis
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
…
next ›
last »